JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC.

Nos. 2022-1258, 2022-1307.

JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV, Plaintiffs-Appellees, v. TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LTD., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: April 1, 2024.


Attorney(s) appearing for the Case

BARBARA MULLIN , Patterson Belknap Webb & Tyler LLP, New York, NY, argued for plaintiffs-appellees. Also represented by ANDREW D. COHEN , ARON RUSSELL FISCHER , MEGHAN LARYWON .

JOHN C. O'QUINN , Kirkland & Ellis LLP, Washington, DC, argued for all defendants-appellants. Defendant-appellant Teva Pharmaceuticals USA, Inc. also represented by WILLIAM H. BURGESS ; CHRISTOPHER T. JAGOE , JEANNA WACKER , New York, NY.

DEEPRO MUKERJEE , Katten Muchin Rosenman LLP, for defendant-appellant Mylan Laboratories Ltd. Also represented by LANCE SODERSTROM ; JITENDRA MALIK , Charlotte, NC; JILLIAN SCHURR , Chicago, IL; ERIC THOMAS WERLINGER , Washington, DC.

Before DYK, PROST, and HUGHES,


Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV (collectively, "Janssen") sued Teva Pharmaceuticals USA, Inc. ("Teva") for patent infringement in the United States District Court for the District of New Jersey. Janssen asserted U.S. Patent No. 9,439,906 ("the '906 patent"). Teva stipulated to infringement but challenged...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases